Voltage-Gated N-Type and T-Type Calcium Channels and Excitability Disorders

Structure, Function, and Modulation of Neuronal Voltagegated Ion Channels

Volumn , Issue , 2008, Pages 35-66

  Tringham, Elizabeth ^a   Snutch, Terrance P ^a,b  

^a Neuromed Pharmaceuticals   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

N type and T type calcium channels in pathophysiological condition; T type channel contribution and epilepsy pathophysiology; Voltage gated N type and T type calcium channels

Indexed keywords

EID: 84891280385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470429907.ch2     Document Type: Chapter

References (217)

1. Adams DJ, Smith AB, Schroeder CI, Yasuda T, Lewis RJ, 2003. Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J Biol Chem 278 (6): 4057-4062.
2. Altier C, Dale CS, Kisilevsky AE, Chapman K, Castiglioni AJ, Matthews EA, Evans RM, Dickenson AH, Lipscombe D, Vergnolle N, Zamponi GW, 2007. Differential role of N-type calcium channel splice isoforms in pain. J Neurosci 27 (24): 6363-6373.
3. Babbedge RC, Soper AJ, Gentry CT, Hood VC, Campbell EA, Urban L, 1996. In vitro characterization of a peripheral afferent pathway of the rat after chronic sciatic nerve section. J Neurophysiol 76 (5): 3169-3177.
4. Baccei ML, Kocsis JD, 2000. Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. J Neurophysiol 83 (4): 2227-2238.
5. Barton ME, Eberle EL, Shannon HE, 2005. The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Pharmacol 521(1-3): 79-85.
6. Becker A, Grecksch G, 1995. Flunarizine-its effect on pentylenetetrazol-kindled seizures and on related cognitive disturbances. Pharmacol Biochem Behav 52 (4): 765-769.
7. Bell TJ, Thaler C, Castiglioni AJ, Helton TD, Lipscombe D, 2004. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41 (1): 127-138.
8. Bennett GJ, Xie YK, 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1): 87-107.
9. Blake DW, Scott DA, Angus JA, Wright CE, 2005. Synergy between intrathecal omega-conotoxin CVID and dexmedetomidine to attenuate mechanical hypersensitivity in the rat. Eur J Pharmacol 506 (3): 221-227.
10. Boland LM, Morrill JA, Bean BP, 1994. Omega-conotoxin block of N-type calcium channels in frog and rat sympathetic neurons. J Neurosci 14: 5011-5027.
11. Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB, 2000. Potent analgesic effects of GDNF in neuropathic pain states. Science 290 (5489): 124-127.
12. v3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24 (2): 315-324.
13. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX, Luther RR, 1996. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinoci-ception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 279: 1243-1249.
14. Broicher T, Kanyshkova T, Landgraf P, Rankovic V, Meuth P, Meuth SG, Pape HC, Budde T, 2007a. Specific expression of low-voltage-activated calcium channel isoforms and splice variants in thalamic local circuit interneurons. Mol Cell Neurosci 36: 132-145.
15. 2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. Neuro-pharmacology 53 (3): 431-446.
16. Brose WG, Gutlove DP, Luther RR, Bowersox SS, McGuire D, 1997. Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clin J Pain 13 (256): 259-.
17. Carbone E, Lux HD, 1984a. A low voltage-activated calcium conductance in embryonic chick sensory neurons. Biophys J 46(3): 413-418.
18. Carbone E, Lux HD, 1984b. A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurons. Nature 310 (5977): 501-502.
19. Chen Y, Lu J, Pan H, Zhang Y, Wu H, Xu K, Liu X, Jiang Y, Bao X, Yao Z, Ding K, Lo WH, Qiang B, Chan P, Shen Y, Wu X, 2003a. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 54 (2): 239-243.
20. Chen Y, Lu J, Zhang Y, Pan H, Wu H, Xu K, Liu X, Jiang Y, Bao X, Zhou J, Liu W, Shi G, Shen Y, Wu X, 2003b. T-type calcium channel gene alpha (1G) is not associated with childhood absence epilepsy in the Chinese Han population. Neurosci Lett 341 (1): 29-32.
21. 2+ channels, KATP channels or N-methyl-D-aspartic acid receptors? Anesth Analg 102(1): 182-187.
22. Cheng JK, Lin CS, Chen CC, Yang JR, Chiou LC, 2007. Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test. Behav Pharmacol 8 (1): 1-8.
23. Chioza B, Everett K, Aschauer H, Brouwer O, Callenbach P, Covanis A, Dulac O, Durner M, Eeg-Olofsson O, Feucht M, Friis M, Heils A, Kjeldsen M, Larsson K, Lehesjoki AE, Nabbout R, Olsson I, Sander T, Siren A, Robinson R, Rees M, Gardiner RM, 2006. Evaluation of CACNA1H in European patients with childhood absence epilepsy. Epilepsy Res 69 (2): 177-181.
24. Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, Park J, Chen CC, Campbell KP, Shin HS, 2007. Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav 6 (5): 425-431.
25. 2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 147 (4): 456-463.
26. Coulter DA, Huguenard JR, Prince DA, 1989a. Calcium currents in rat thalamocortical relay neurones: kinetic properties of the transient low-threshold current J Physiol 414: 587-604.
27. Coulter DA, Huguenard JR, Prince DA, 1989b. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25 (6): 582-593.
28. Craig PJ, Beattie RE, Folly EA, Banerjee MD, Reeves MB, Priestley JV, Carney SL, Sher E, Perez-Reyes E, Volsen SG, 1999. Distribution of the voltage-dependent calcium channel alpha1G subunit mRNA and protein throughout the mature rat brain. Eur J Neurosci 11 (8): 2949-2964.
29. Czapinski P, Blaszczyk B, Czuczwar SJ, 2005. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5 (1): 3-14.
30. Dailey JW, Yan QS, Adams-Curtis LE, Ryu JR, Ko KH, Mishra PK, Jobe PC, 1996. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci 58 (4): 259-266.
31. Deak F, Lasztoczi B, Pacher P, Petheo GL, Kecskemeti V, Spat A, 2000. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharma-cology 39 (6): 1029-1036.
32. De la Pena E, Geijo-Barrientos E, 1996. Laminar localization, morphology, and physiological properties of pyramidal neurons that have the low-threshold calcium current in the guinea-pig medial frontal cortex. J Neurosci 16 (17): 5301-5311.
33. De Sarro GB, Nistico G, Meldrum BS, 1986. Anticonvulsant properties of flunarizine on reflex and generalized models of epilepsy. Neuropharmacology 25 (7): 695-701.
34. De Sarro GB, De Sarro A, Trimarchi GR, Nistico G, 1992. Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2mice. Gen Pharmacol 23 (1): 75-82.
35. Deschenes M, Paradis M, Roy JP, Steriade M, 1984. Electrophysiology of neurons of lateral thalamic nuclei in cat: resting properties and burst discharges. J Neurophysiol 51 (6): 1196-1219.
36. Desmedt LK, Niemegeers CJ, Janssen PA, 1975. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice. Arzneimittelforschung 25 (9): 1408-1413.
37. Destexhe A, Sejnowski TJ, 2002. The initiation of bursts in thalamic neurons and the cortical control of thalamic sensitivity. Philos Trans R Soc Lond B Biol Sci 357 (1428): 1649-1657.
38. Devor M, Janig W, Michaelis M, 1994. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol 71 (1): 38-47.
39. Diaz A, Dickenson AH, 1997. Blockade of spinal N-and P-type but not L-type calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation. Pain 69(1-2): 93-100.
40. Dickenson AH, Sullivan AF, 1987. Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30 (3): 349-360.
41. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN, 2006. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 26 (4): 1281-1292.
42. Dogrul A, Ye§ilyurt O, I§imer A, Guzeldemir ME, 2001. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 93 (1): 61-68.
43. Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, Porreca F, 2003. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105(1-2): 159-168.
44. Drago F, Valerio C, Clementi G, Scapagnini U, 1986. Effects of flunarizine on experimentally induced convulsions in animals. Funct Neurol 1 (4): 529-532.
45. Drake ME, Greathouse NI, Renner JB, Armentbright AD, 2004. Open-label zonisamide for refractory migraine. Clin Neuropharmacol 27 (6): 278-280.
46. Dubel SJ, Starr TV, Hell J, Ahlijanian MK, Enyeart JJ, Catterall WA, Stch TP, 1992. Molecular cloning of the alpha-1 subunit of an omega-conotoxin sensitive calcium channel. Proc Natl Acad Sci USA 89 (5058): 5062-.
47. Dubreuil AS, Boukhaddaoui H, Desmadryl G, Martinez-Salgado C, Moshourab R, Lewin GR, Carroll P, Valmier J, Scamps F, 2004. Role of T-type calcium current in identified D-hair mechanoreceptor neurons studied in vitro. J Neurosci 24 (39): 8480-8484.
48. Durrheim DN, Joubert J, Griesel RD, 1992. Flunarizine-effective add-on therapy in reading epilepsy. S Afr Med J 82 (1): 21-23.
49. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11 (6): 723-739.
50. Evans AR, Nicol GD, Vasko MR, 1996. Differential regulation of evoked peptide release by voltage-sensitive calcium channels in the rat sensory neurons. Brain Res 712 (265): 273-.
51. Faas GC, Vreugdenhil M, Wadman WJ, 1996. Calcium currents in pyramidal CA1 neurons in vitro after kindling epileptogenesis in the hippocampus of the rat. Neuroscience 75 (1): 57-67.
52. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C, 1995. Anticonvulsant effect of fluoxetine in humans. Neurology 45 (10): 1926-1927.
53. Feng ZP, Doering CJ, Winkfein RJ, Beedle AM, Spafford JD, Zamponi GW, 2003. Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA. J Biol Chem 278 : 20171-20178.
54. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH, 2005. Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain 118 (3): 289-305.
55. Flatters SJ, Bennett GJ, 2004. Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy. Pain 109(1-2): 150-161.
56. Foong FW, Satoh M, 1983. Analgesic potencies of non-narcotic, narcotic and anesthetic drugs as determined by the bradykinin-induced biting-like responses in rats. Jpn J Pharmacol 33 (5): 933-938.
57. Fuchs A, Rigaud M, Sarantopoulos CD, Filip P, Hogan QH, 2007. Contribution of calcium channel subtypes to the intracellular calcium signal in sensory neurons: the effect of injury. Anesthesiology 107 (1): 117-127.
58. 2+-channel blockers potentiate morphine analgesia in mice. Life Sci 73: 2873-2881.
59. Fukuizumi T, Ohkubo T, Kitamura K, 2003b. Spinal sensitization mechanism in vincristine-induced hyperalgesia in mice. Neurosci Lett 343: 89-92.
60. Gasior M, Kaminski R, Brudniak T, Kleinrok Z, Czuczwar SJ, 1996. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentyl-enetetrazol in mice. J Neural Transm 103 (7): 819-831.
61. Gasior M, Ungard JT, Witkin JM, 1999. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 290 (3): 1148-1156.
62. Gohil K, Bell JR, Ramachandran J. Miljanich GP, 1994. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (co-conopeptide MVIIC). Brain Res 653 (258): 266-.
63. Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E, 2001. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol 60 (1121): 1132-.
64. Green MW, Selman JE, 1991. Review article: the medical management of trigeminal neuralgia. Headache 31 (9): 588-592.
65. Gruner W. Silva LR, 1994. c -Conotoxin sensitivity and presynaptic inhibition ofglutamatergic sensory neurotransmission in vitro. J Neurosci 14 (2800): 2808-.
66. Guay DR, 2003. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. Am J Geriatr Pharmacother 1 (1): 18-37.
67. Harper AA, Lawson SN, 1985a. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurons. J Physiol 359: 31-46.
68. Harper AA, Lawson SN, 1985b. Electrical properties of rat dorsal root ganglion neurons with different peripheral nerve conduction velocities. J Physiol 359: 47-63.
69. 2+ channels by G-protein beta gamma subunits. Nature 380 (6571): 258-262.
70. Heron SE, Phillips HA, Mulley JC, Mazarib A, Neufeld MY, Berkovic SF, Scheffer IE, 2004. Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann Neurol 55: 595-596.
71. Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, Scheffer IE, Berkovic SF, Mulley JC, Zamponi GW, 2007. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol 62 (6): 560-568.
72. Hildebrand ME, Snutch TP, 2006. Contributions of T-type calcium channels to the pathophysiology of pain signaling. Drug Discovery Today: Dis. Mech. 3 (335): 341-.
73. Hogan QH, 2007. Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain. Croat Med J 48 (1): 9-21.
74. Holz GG, Dunlap K, Kream RM, 1988. Characterization of the electrically evoked release of substance P from dorsal root ganglion neurons: methods and dihydropyridine sensitivity. J Neurosci 8 (463): 471-.
75. Hord AH, Denson DD, Chalfoun AG, Azevedo MI, 2003. The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy. Anesth Analg 96 (6): 1700-1706.
76. 2+ channels is an important action of succinimide antiabsence drugs. Epilepsy Curr 2 (2): 49-52.
77. 2+-dependent burst firing in GABAergic neurons of rat thalamic reticularnucleus. J Neurosci 12(10): 3804-3817.
78. Huguenard JR, Prince DA, 1994. Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. J Neurosci 14 (9): 5485-5502.
79. Ikeda SR, 1996. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature 380 (6571): 255-258.
80. Ikeda SR, Dunlap K, 2007. Calcium channels diversify their signaling portfolio. Nat Neurosci 10 (3): 269-271.
81. Ino M, Yoshinaga T, Wakamori M, Miyamoto N, Takahashi E, Sonoda J, Kagaya T, Oki T, Nagasu T, Nishizawa Y, Tanaka I, Imoto K, Aizawa S, Koch S, Schwartz A, Niidomem T, Sawada K, Mori Y, 2001. Functional disorders of the sympathetic nervous system in mice lacking the a1B subunit (Cav2.2) of N-type calcium channels. Proc Natl Acad Sci USA 98 (5323): 5328-.
82. Isope P, Murphy TH, 2005. Low threshold calcium currents in rat cerebellar Purkinje cell dendritic spines are mediated by T-type calcium channels. J Physiol 562(Part 1): 257-269.
83. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, Rosenberg ER, Bayliss DA, Jevtovic-Todorovic V, Todorovic SM, 2007. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27 (12): 3305-3316.
84. Jahnsen H, Llinas R, 1984. Ionic basis for the electro-responsiveness and oscillatory properties of guinea-pig thalamic neurones in vitro. J Physiol 349 (227): 247-.
85. Jimenez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, Nargeot J, 2000. Determinants of voltage-dependent inactivation affect mibefradil block of calcium channels. Neurophar-macology 39 (1): 1-10.
86. Joseph S, David J, Joseph T, 1998a. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice. Indian J Physiol Pharmacol 42 (3): 383-388.
87. Joseph S, David J, Joseph T, 1998b. Synergistic effect of flunarizine and sodium valproate on seizure thresholds elicited by cortical stimulation in conscious rats. Indian J Physiol Pharmacol 42 (1): 39-49.
88. Jung HY, Staff NP, Spruston N, 2001. Action potential bursting in subicular pyramidal neurons is driven by a calcium tail current. J Neurosci 21 (10): 3312-3321.
89. Kajander KC, Bennett GJ, 1992. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J Neurophysiol 68 (3): 734-744.
90. Kajander KC, Wakisaka S, Bennett GJ, 1992. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett 138 (2): 225-228.
91. Karst H, Joels M, Wadman WJ, 1993. Low-threshold calcium current in dendrites of the adult rat hippocampus. Neurosci Lett 164(1-2): 154-158.
92. 2+ channels in synaptic transmission. Br J Pharmacol 135 (5): 1336-1342.
93. Kelly KM, Gross RA, Macdonald RL, 1990. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett 116(1-2): 233-238.
94. Kerr LM, Filloux F, Olivera BM, Jackson H, Wamsley JK, 1988. Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain. Eur J Pharmacol 146 (181): 183-.
95. v3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem 279(11): 9681-9684.
96. v3.2 channel mutations linked to idiopathic generalized epilepsy. Ann Neurol 57 (5): 745-749.
97. Kim C, Jun K, Lee T, Kim S-S, McEnery MW, Chin H, Kim H-L, Park JM, Kim DW, Jung SJ, Kim J, Shin H-S, 2001. Altered nociceptive response in mice deficient in the a1B subunit of the voltage-dependent Ca channel. Mol Cell Neurosci 18 (235): 245-.
98. 2+ channels. Neuron 31 (1): 35-45.
99. 2+ channels. Science 302 (5642): 117-119.
100. Kito M, Maehara M, Watanabe K, 1996. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 5 (2): 115-119.
101. Koyano K, Abe T, Nishiuchi Y, Sakakibara S, 1987. Effects of synthetic omega-conotoxin on synaptic transmission. Eur J Pharmacol 135 (3): 337-343.
102. v3.2 & CACNG2) in genetic absence epilepsy rats from Strasbourg. Australian Neuroscience Society, Online 2006, Abstract Viewer and Itinerary Planner, Program No. ORAL-11-03.
103. Lacinova L, Klugbauer N, Hofmann F, 2000. Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers. Neuropharmacology 39 (7): 1254-1266.
104. Leander JD. 1992. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvul-sant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia 33(3): 573-576.
105. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, Gomez F, Acosta E, Arocha L, Villa S, 1989. Pimozide therapy for trigeminal neuralgia. Arch Neurol 46 (9): 960-963.
106. Leresche N, Parri HR, Erdemli G, Guyon A, Turner JP, Williams SR, Asprodini E, Crunelli V, 1998. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. J Neurosci 18 (13): 4842-4853.
107. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, Luchian T, Adams DJ, Bond T, Thomas L, Jones A, Matheson JL, Drinkwater R, Andrews PR, Alewood PF, 2000. Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275: 35335-35344.
108. Lia EN, Prado WA, 1999. Effects of intrathecal L-and N-type calcium channel blockers on the antinociception evoked by opioid agonists in the rat tail flick test. Acta Physiol Pharmacol Ther Latinoam 49 (4): 195-203.
109. Liang J, Zhang Y, Wang J, Pan H, Wu H, Xu K, Liu X, Jiang Y, Shen Y, Wu X, 2006. New variants in the CACNA1H gene identified in childhood absence epilepsy. Neurosci Lett 406 (1-2): 27-32.
110. Liang J, Zhang Y, Chen Y, Wang J, Pan H, Wu H, Xu K, Liu X, Jiang Y, Shen Y, Wu X, 2007. Common polymorphisms in the CACNA1H gene associated with childhood absence epilepsy in Chinese Han population. Ann Hum Genet 71 (Part 3): 325-335.
111. Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, Devor M, 2000. Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain 85 (3): 503-521.
112. Llinas R, Jahnsen H, 1982. Electrophysiology of mammalian thalamic neurones in vitro. Nature 297 (5865): 406-408.
113. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL, 2001. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21 (6): 1868-1875.
114. Mack CM, Gilbert ME, 1992. An examination of the anticonvulsant properties of voltage-sensitive calcium channel inhibitors in amygdala kindled seizures. Psychopharmacology (Berl) 106 (3): 365-369.
115. Malmberg AB, Yaksh TL, 1994. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N-and P-type channels inhibits formalin-induced nociception. J Neurosci 14 (4882): 4890-.
116. Malmberg AB, Yaksh TL, 1995. Effect of continuous intrathecal infusion of omega-con-opeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60 (1): 83-90.
117. 2+ channels in apical dendrites of rat CA1 pyramidal neurons. J Physiol 487 (Part 1): 67-90.
118. Maggi CA, Tramontana M, Cecconi R, Santicioli P, 1990. Neurochemical evidence for the involvement of N-type calcium channels in transmitter secretion from peripheral endings of sensory nerves in guinea pigs. Neurosci Lett 144 (203): 206-.
119. Manning JP, Richards DA, Leresche N, Crunelli V, Bowery NG, 2004. Cortical-area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 123 (1): 5-9.
120. Markram H, Sakmann B, 1994. Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels. Proc Natl Acad Sci USA 91 (11): 5207-5211.
121. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA, 2000. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295 (1): 302-308.
122. Mathur VS, 2000. Ziconotide: a new pharmacological class of drug for the management of pain. Semin Anesth Perioperat Med Pain 19 (67): 75-.
123. Matsuki N, Quandt FN, Ten Eick RE, Yeh JZ, 1984. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther 228 (2): 523-530.
124. 2+ channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 415(2-3): 141-149.
125. Matthews EA, Dickenson AH, 2001b. Effects of spinally delivered N-and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92(1-2): 235-246.
126. McCall WD, Tanner KD, Levine JD, 1996. Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 208 (1): 45-48.
127. McCallum JB, Kwok WM, Mynlieff M, Bosnjak ZJ, Hogan QH, 2003. Loss of T-type calcium current in sensory neurons of rats with neuropathic pain. Anesthesiology 98 (1): 209-216.
128. McCleane GJ, 1999. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg 89 (4): 985-988.
129. McKay BE, McRory JE, Molineux ML, Hamid J, Snutch TP, Zamponi GW, Turner RW, 2006. Ca(V)3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons. Eur J Neurosci 24 (9): 2581-2594.
130. McLachlan EM, Janig W, Devor M, Michaelis M, 1993. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 363 (6429): 543-546.
131. Meeren HK, Pijn JP, Van Luijtelaar EL, Coenen AM, Lopes da Silva FH, 2002. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22 (4): 1480-1495.
132. 2+ currents in dendritic recordings from Purkinje cells in rat cerebellar slice cultures. J Neurosci 17(1): 160-170.
133. 2+ channels at the primary afferent neurons in mice. Eur J Pharmacol 419(2-3): 175-181.
134. Murakami M, Nakagawasai O, Suzuki T, Mobarakeh II, Sakurada Y, Murata A, Yamadera F, Miyoshi I, Yanai K, Tan-No K, Sasano H, Tadano T, Iijima T, 2004. Antinociceptive effect of different types of calcium channels inhibitors and the distribution of the various calcium channel a1 subunits in the dorsal horn of spinal cord in mice. Brain Res 1024 (122): 129-.
135. Nahm SS, Jung KY, Enger MK, Griffith WH, Abbott LC, 2005. Differential expression of T-type calcium channels in P/Q-type calcium channel mutant mice with ataxia and absence epilepsy. J Neurobiol 62 (3): 352-360.
136. Nebe J, Vanegas H, Schaible H, 1998. Spinal application of co-conotoxin-GVIA, an N-type calcium channel antagonist, attenuates enhancement of dorsal spinal neuronal responses caused by intra-articular injection of mustard oil in the rat. Exp Brain Res 120 (61): 69-.
137. 2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J Neurosci 25 (38): 8766-8775.
138. Neugebauer V, Vanegas H, Nebe J, Riimenapp P, Schaible HG, 1996. Effects of N-and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and inflamed knee joint. J Neurophysiol 76 (6): 3740-3749.
139. Niedermeyer E, 1996. Primary (idiopathic) generalized epilepsy and underlying mechanisms. Clin Electroencephalogr 27 (1): 1-21.
140. Nielsen KJ, Schroeder T, Lewis R, 2000. Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels. J Mol Recognit 13 (55): 70-.
141. Nowycky MC, Fox AP, Tsien RW, 1985. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316 (440): 443-.
142. Olivera BM, McIntosh JM, Cruz LJ, Luque FA, Gray WR, 1984. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 23 (5087): 5090-.
143. Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Santos V, Cruz LJ, 1985. Peptide neurotoxins from fish-hunting cone snails. Science 230: 1338-1343.
144. Olivera BM, Cruz LJ, de Santos V, LeCheminant GW, Griffin D, Zeikus R, McIntosh JM, Galyean R, Varga J, Gray WR, 1987. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 26 (2086): 2090-.
145. Omote K, Kawamata M, Satoh O, Iwasaki H, Namiki A, 1996. Spinal antinociceptive action of an N-type voltage-dependent calcium channel blocker on the synergistic interaction with morphine. Anesthesiology 84 (3): 636-643.
146. Pathirathna S, Brimelow BC, Jagodic MM, Krishnan K, Jiang X, Zorumski CF, Mennerick S, Covey DF, Todorovic SM, Jevtovic-Todorovic V, 2005a. New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids. Pain 114 (3): 429-443.
147. Pathirathna S, Todorovic SM, Covey DF, Jevtovic-Todorovic V, 2005b 5Alpha-reduced neuroactive steroids alleviate thermal and mechanical hyperalgesia in rats with neuropathic pain. Pain 117(3): 326-339.
148. Pathirathna S, Covey DF, Todorovic SM, Jevtovic-Todorovic V, 2006. Differential effects of endogenous cysteine analogs on peripheral thermal nociception in intact rats. Pain 125(1-2): 53-64.
149. v3.2 T-type calcium channel mutations linked to childhood absence epilepsy. Epilepsia 47 (3): 655-658.
150. Penn RD, Paice JA, 2000. Adverse effects associated with the intrathecal administration of ziconotide. Pain 85(1-2): 291-296.
151. Perez-Reyes E, 2003. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83 (1): 117-161.
152. Petersen M, Zhang J, Zhang JM, LaMotte RH, 1996. Abnormal spontaneous activity and responses to norepinephrine in dissociated dorsal root ganglion cells after chronic nerve constriction. Pain 67(2-3): 391-397.
153. Pfrieger FW, Veselovsky NS, Gottmann K, Lux HD, 1992. Pharmacological characterization of calcium currents and synaptic transmission between thalamic neurons invitro. J Neurosci 12 (11): 4347-4357.
154. Pledger GW, Sackellares JC, Treiman DM, Pellock JM, Wright FS, Mikati M, Sahlroot JT, Tsay JY, Drake ME, Olson L, 1994. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology 44 (10): 1830-1836.
155. Pohl M, Mares P, 1987. Effects of flunarizine on metrazol-induced seizures in developing rats. Epilepsy Res 1 (5): 302-305.
156. Polack PO, Guillemain I, Hu E, Deransart C, Depaulis A, Charpier S, 2007. Deep layer somatosensory cortical neurons initiate spike-and-wave discharges in a genetic model of absence seizures. J Neurosci 27 (24): 6590-6599.
157. Prendiville S, Gale K, 1993. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 34 (2): 381-384.
158. Raingo J, Castiglioni AJ Lipscombe D, 2007. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat Neurosci 10 (3): 285-292.
159. Ramer MS, French GD, Bisby MA, 1997. Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG. Pain 72(1-2): 71-78.
160. Richards DA, Manning JP, Barnes D, Rombola L, Bowery NG, Caccia S, Leresche N, Crunelli V, 2003. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy. Epilepsy Res 54(2-3): 97-107.
161. Rodger C, Pleuvry BJ, 1993. Protective effect of flunarizine and nifedipine alone and in combination with anticonvulsant drugs against PTZ-induced seizures in mice. Neurophar-macology 32 (3): 257-263.
162. Rojas-Piloni G, Dickenson AH, Condes-Lara M, 2007. Superficial dorsal horn neurons with double spike activity in the rat. Neurosci Lett 419 (2): 147-152.
163. Saddi G, Abbott FV, 2000. The formalin test in the mouse: a parametric analysis of scoring properties. Pain 89 (1): 53-63.
164. Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, Tanabe T, 2001. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca channel. EMBO J 20 (2349): 2356-.
165. 2+ channels on pain transmission. Neurosci Res 43 (1): 7-.
166. Sakaue A, Honda M, Tanabe M, Ono H, 2004. Antinociceptive effects of sodium channel-blocking agents on acute pain in mice. J Pharmacol Sci 95 (2): 181-188.
167. Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, Parker D, Stea A, Snutch TP, 2002. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci 22 (2): 396-403.
168. Santicioli P, Del Bianco E, Tramontana M, Geppetti P, Maggi CA, 1992. Release of calcitonin gene-related peptide like immunoreactivity induced by electrical stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels. Neurosci Lett 136 (161): 164-.
169. Schroeder JE, Fischbach PS, McCleskey EW, 1990. T-type calcium channels: heterogeneous expression in rat sensory neurons and selective modulation by phorbol esters. J Neurosci 10 (3): 947-951.
170. Scott DA, Wright CE, Angus JA, 2002. Actions of intrathecal c -conotoxins CVIA, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharm 451 (279): 286-.
171. Scroggs RS, Fox AP, 1992. Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J Physiol 445 (639): 658-.
172. Sherwin AL, 1989. Ethosuximide: clinical use. In: Levy, RH, Mattson, R., Meldrum, B, Penry, JK, Drisfuss, FE, (Eds), Antiepileptic Drugs. Raven Press, New York, pp. 685-689.
173. Shin JB, Martinez-Salgado C, Heppenstall PA, Lewin GR, 2003. A T-type calcium channel required for normal function of a mammalian mechanoreceptor. Nat Neurosci 6 (7): 724-730.
174. Silva LR, Amitai Y, Connors BW, 1991. Intrinsic oscillations of neocortex generated by layer 5 pyramidal neurons. Science 251 (4992): 432-435.
175. Singh B, Monteil A, Bidaud I, Sugimoto Y, Suzuki T, Hamano S, Oguni H, Osawa M, Alonso ME, Delgado-Escueta AV, Inoue Y, Yasui-Furukori N, Kaneko S, Lory P, Yamakawa K, 2007. Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Hum Mutat 28 (5): 524-525 (Mutation in brief #962 Online).
176. Sluka KA, 1997. Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain 71 (157): 164-.
177. Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ, 2002. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96(1-2): 119-127.
178. Snutch TP, 2008. Voltage-gated calcium channel. The New Encyclopedia of Neuroscience, edited by L. Squire et al.
179. Song XJ, Hu SJ, Greenquist KW, Zhang JM, LaMotte RH. 1999. Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J Neurophysiol 82 (6): 3347-3358.
180. Song I, Kim D, Choi S, Sun M, Kim Y, Shin HS, 2004. Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. J Neurosci 24 (22): 5249-5257.
181. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce D, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D, 2004. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. J Am Med Assoc 291 (63): 70-.
182. Starreveld E, de Beukelaar F, Wilson AF, McLean DR, Findlay HP. 1989. Double-blind crossover placebo controlled study of flunarizine in patients with therapy resistant epilepsy. Can J Neurol Sci 16(2): 187-190.
183. Steriade M, Contreras D, 1998. Spike-wave complexes and fast components of cortically generated seizures. I. Role of neocortex and thalamus. J Neurophysiol 80 (3): 1439-1455.
184. 2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci 22 (9): 3645-3655.
185. Suh HW, Song DK, Choi SR, Huh SO, Kim YH, 1997. Differential effects of co-conotoxin GVIA, nimodipine, calmidazolium and KN-62 injected intrathecally on the antinociception induced by b-endorphin, morphine and [D-Ala2, N-MePhe4, Gly-ol5]-enkephalin administered intracerebroventrically in the mouse. J Pharmacol Exp Ther 282 (961): 966-.
186. Suzuki S, Kawakami K, Nishimura S, Watanabe Y, Yagi K, Seino M, Miyamoto K, 1992. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 12 (1): 21-27.
187. Takahashi Y, Hashimoto K, Tsuji S, 2004. Successful use of zonisamide for central poststroke pain. J Pain 5 (3): 192-194.
188. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA, 1999. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19 (6): 1895-1911.
189. Talley EM, Solorzano G, Depaulis A, Perez-Reyes E, Bayliss DA, 2000. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 75 (1): 159-165.
190. 2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. JNeurophysiol 79 (1): 240-252.
191. 2+ current in adult rat sensory neurons by a steroid that lacks gamma-aminobutyric acid-modulatory activity. Mol Pharmacol 54 (5): 918-927.
192. Todorovic SM, Perez-Reyes E, Lingle CJ, 2000. Anticonvulsants but not general anesthetics have differential blocking effects on different T-type current variants. Mol Pharmacol 58 (1): 98-108.
193. Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C, Olney JW, Zorumski CF, 2001. Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 31 (1): 75-85.
194. 2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia. Pain 109 (3): 328-339.
195. Trommer BL, Pasternak JF, 1989. Flunarizine does not delay the development of generalized seizures by amygdala kindling. Epilepsy Res 4 (3): 230-233.
196. Tsakiridou E, Bertollini L, de Curtis M, Avanzini G, Pape HC, 1995. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 15 (4): 3110-3117.
197. Twombly DA, Yoshii M, Narahashi T, 1988. Mechanisms of calcium channel block by phenytoin. J Pharmacol Exp Ther 246 (1): 189-195.
198. Urban MO, Ren K, Sablad M, Park KT. 2005. Medullary N-type and P/Q-type calcium channels contribute to neuropathy-induced allodynia. Neuroreport 16(6): 563-566.
199. Vitko I, Chen Y, Arias JM, Shen Y, Wu XR, Perez-Reyes E, 2005. Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel. J Neurosci 25 (19): 4844-4855.
200. 2+ channels: a paradigm for childhood absence epilepsy mutations. J Neurosci 27 (2): 322-330.
201. Wada Y, Shiraishi J, Nakamura M, Hasegawa H, 1995. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychophar-macology (Berl) 118 (3): 305-309.
202. Wagner JA, Snowman AM, Biswas A, Olivera BM, Snyder SH, 1988. Omega-conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization. J Neurosci 8 (3354): 3359-.
203. Wall PD, Devor M, 1983. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 17 (4): 321-339.
204. Wallace MS, 2006. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 6 (10): 423-428.
205. Wang YX, Bezprozvannaya S, Bowersox SS, Nadasdi L, Miljanich G, Mezo G, Silva D, Tarczy-Hornoch K, Luther RR, 1998. Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers. Naunyn Schmiedebergs Arch Pharmacol 357 (159): 168-.
206. Wang J, Zhang Y, Liang J, Pan H, Wu H, Xu K, Liu X, Jiang Y, Shen Y, Wu X, 2006. CACNA1I is not associated with childhood absence epilepsy in the Chinese Han population. Pediatr Neurol 35 (3): 187-190.
207. Westenbroek RE, Hell JW, Warner C, Dubel SJ, Snutch TP, Catterall WA, 1992. Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron 9 (1099): 1115-.
208. 2+ current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Natl Acad Sci USA 86 (17): 6802-6806.
209. Williams DS, 1950. A study of thalamic and cortical rhythms in petit mal. Brain 67 (50): 69-.
210. Winter J, Brevan S, Campbell EA. 1995. Capsaicin and pain mechanisms. Br J Anaesth 75:157-168.
211. Wong DT, Bymaster FP, Engleman EA, 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57 (5): 411-441.
212. Wu G, Ringkamp M, Hartke TV, Murinson BB, Campbell JN, Griffin JW, Meyer RA, 2001. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 21(8): RC140.
213. Xiao WH, Bennett GJ, 1995. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther 274(2): 666-672.
214. Yamamoto T, Sakashita Y, 1998. Differential effects of intrathecally administered N-and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res 794 (329): 332-.
215. Yokoyama K, Kurihara T, Makita K, Tanabe T, 2003. Plastic change in N-type Ca channel expression after preconditioning is responsible for prostaglandin E2-induced long-lasting allodynia. Anesthesiology 99 (6): 1364-1370.
216. Zhang J M. Song XJ, LaMotte RH, 1999. Enhanced excitability of sensory neurons in rats with cutaneous hyperalgesia produced by chronic compression of the dorsal root ganglion. J Neurophysiol 82 (6): 3359-3366.
217. Zhang Y, Mori M, Burgess DL, Noebels JL, 2002. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 22 (15): 6362-6371.